<DOC>
	<DOCNO>NCT00112294</DOCNO>
	<brief_summary>The primary purpose clinical research study learn patient treated combination Taxane/Carboplatin plus Cetuximab ( C/T/C ) longer progression-free survival patient treat Taxane/Carboplatin ( T/C ) alone . The safety treatment also study .</brief_summary>
	<brief_title>Study Taxane/Carboplatin +/- Cetuximab First-Line Treatment Patients With Advanced/Metastatic Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Must advance metastatic nonsmall cell lung cancer previously treat chemotherapy . Tumor/disease lesion measure bidimensionally . Must able carryout work light sedentary nature ( e.g . light house work , office work ) . Adequate recovery recent surgery radiation therapy . Must least 4 week last major surgery prior treatment investigational agent . At least 12 week radiation therapy chest . Accessible treatment , followup require visit participate center ( ) . Prior chemotherapy adjuvant chemotherapy treatment lung cancer . Prior treatment cetuximab epidermal growth factor ( EGFR ) target therapy . Prior severe infusion reaction antibody therapy . Concurrent malignancy ( previous malignancy without evidence disease 5 year allow enter trial ) . Concurrent chemotherapy therapy another investigational agent indicate protocol . Serious uncontrolled medical disorder would impair ability receive therapy . History myocardial infarction within prior 3 month , uncontrolled angina , uncontrolled arrhythmia , uncontrolled congestive heart failure . Symptomatic uncontrolled metastasis central nervous system . Subjects receive glucocorticoid central nervous system ( CNS ) metastases eligible , receive anticonvulsant eligible . Peripheral neuropathy &gt; = grade 2 ( Common Toxicity Criteria Adverse Event [ CTCAE ] Version 3.0 ) . Inadequate hematologic and/or liver and/or kidney function . Sexually active fertile individual partner individual unwilling unable use acceptable method birth control entire trial 4 week study . Women pregnant breastfeeding . Women positive pregnancy test enrollment prior study drug administration . Altered mental status psychiatric condition prohibits understand render consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Non-Small Cell Lung Cancer</keyword>
</DOC>